Trials / Completed
CompletedNCT02966275
Post Bariatric Closed Loop Glucagon Trial
Closed-Loop Glucagon Administration For The Automated Treatment Of Post-Bariatric Hypoglycemia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
This study is to test our automated hypoglycemia prevention and treatment device (glucagon-only bionic pancreas) in subjects that have undergone post-bariatric surgery that are experiencing symptoms of hypoglycemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Glucagon-only bionic pancreas - glucagon | A computer algorithm will automatically deliver glucagon based on the signal from a minimally invasive continuous glucose monitor. |
| DEVICE | Glucagon-only bionic pancreas - placebo | A computer algorithm will automatically deliver placebo based on the signal from a minimally invasive continuous glucose monitor. |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2016-11-17
- Last updated
- 2018-12-13
- Results posted
- 2018-11-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02966275. Inclusion in this directory is not an endorsement.